Phase 0 pharmacodynamic study of mycophenolate mofetil in patients with pancreatic cancer [Estudio farmacodinamico Fase "0" de Micofenolato Mofetil (MMF, CellCept) en pacientes con cancer de pancreas]

Trial Profile

Phase 0 pharmacodynamic study of mycophenolate mofetil in patients with pancreatic cancer [Estudio farmacodinamico Fase "0" de Micofenolato Mofetil (MMF, CellCept) en pacientes con cancer de pancreas]

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Pancreatic cancer
  • Focus Biomarker; Pharmacodynamics
  • Acronyms PROYECTO-FIS
  • Most Recent Events

    • 30 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top